Need a specific person's email?
Browse Precision For Medicine's employee directory (about 2.1K employees) and reveal verified emails free.
Precision For Medicine's most common email format is First.Last@precisionformedicine.com (ex. John.Doe@precisionformedicine.com), used for 96% of precisionformedicine.com addresses. Precision For Medicine uses 4 email patterns.
| Format | Example | Share of precisionformedicine.com |
|---|---|---|
| First.Last@precisionformedicine.comMost common | John.Doe@precisionformedicine.com | |
| First.Middle@precisionformedicine.com | John.Michael@precisionformedicine.com | |
| FL@precisionformedicine.com | JD@precisionformedicine.com | |
| First.MiddleLast@precisionformedicine.com | John.MichaelDoe@precisionformedicine.com |
Browse Precision For Medicine's employee directory (about 2.1K employees) and reveal verified emails free.
Biotechnology ResearchMaryland, United States1001-5000 Employees
Precision for Medicine delivers biomarker-informed clinical research and development services across the full spectrum of drug development, from early studies to regulatory approval, with a focus on oncology and rare diseases. The approach combines clinical operations excellence with laboratory capabilities and data science to inform decisions and improve the predictability of trial outcomes. Its client base comprises pharmaceutical and biotechnology organizations seeking to accelerate therapy development and deepen understanding of patient biology. Headquartered in Bethesda, Maryland, the company operates on a global scale with thousands of professionals across a network of offices worldwide. In 2026 it expanded its Asia-Pacific footprint with new offices in Singapore and Japan. It functions as an operating unit within Precision Medicine Group.
Most common format
First.Last@precisionformedicine.com
Example: John.Doe@precisionformedicine.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.